Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm, and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. It provides devices directly to patients and bill their insurance companies directly. It also sells its products through various other sales channels, including through orthotics and prosthetics providers, the veteran’s administration, and others.
Ticker SymbolMYO
Company nameMyomo Inc
IPO dateJun 12, 2017
CEOMr. Paul R. Gudonis
Number of employees184
Security typeOrdinary Share
Fiscal year-endJun 12
Address137 Portland Street
CityBOSTON
Stock exchangeNYSE American Consolidated
CountryUnited States of America
Postal code02114
Phone16179969058
Websitehttps://myomo.com/
Ticker SymbolMYO
IPO dateJun 12, 2017
CEOMr. Paul R. Gudonis
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data